Financial results - DECAPRISEPT SRL

Financial Summary - Decaprisept Srl
Unique identification code: 32324609
Registration number: J09/616/2013
Nace: 2829
Sales - Ron
355.368
Net Profit - Ron
428
Employees
11
Open Account
Company Decaprisept Srl with Fiscal Code 32324609 recorded a turnover of 2024 of 355.368, with a net profit of 428 and having an average number of employees of 11. The company operates in the field of Fabricarea altor maşini şi utilaje de utilizare generală n.c.a. having the NACE code 2829.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Decaprisept Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 184.573 441.086 233.874 275.319 264.764 421.599 289.164 361.342 312.912 355.368
Total Income - EUR 192.611 457.794 274.261 297.050 285.189 501.555 294.920 381.304 341.182 317.272
Total Expenses - EUR 187.509 410.552 231.901 291.695 278.290 358.116 258.575 354.855 334.849 307.015
Gross Profit/Loss - EUR 5.102 47.243 42.361 5.355 6.898 143.439 36.345 26.449 6.333 10.257
Net Profit/Loss - EUR 4.205 39.322 39.125 2.560 4.249 139.403 33.453 23.010 3.350 428
Employees 5 14 16 18 14 15 12 11 10 11
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 14.2%, from 312.912 euro in the year 2023, to 355.368 euro in 2024. The Net Profit decreased by -2.903 euro, from 3.350 euro in 2023, to 428 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Decaprisept Srl

Rating financiar

Financial Rating -
DECAPRISEPT SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Decaprisept Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Decaprisept Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Decaprisept Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Decaprisept Srl - CUI 32324609

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 14.485 27.738 33.608 148.864 136.400 156.065 132.743 136.140 118.157 106.063
Current Assets 42.237 56.895 66.035 79.145 81.139 181.085 175.902 37.613 75.485 51.110
Inventories 8.532 11.366 46.478 67.194 81.404 153.393 93.425 38.952 73.904 41.604
Receivables 21.807 6.886 9.328 7.850 10.412 52.942 56.041 6.569 7.125 16.508
Cash 11.898 38.643 10.229 4.102 -10.677 -25.251 26.436 -7.908 -5.544 -7.002
Shareholders Funds 5.771 45.035 62.659 64.063 62.955 201.165 166.695 112.314 91.905 76.182
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 50.950 39.598 36.984 163.945 154.585 135.985 141.950 61.438 101.737 80.991
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "2829 - 2829"
CAEN Financial Year 2511
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 51.110 euro in 2024 which includes Inventories of 41.604 euro, Receivables of 16.508 euro and cash availability of -7.002 euro.
The company's Equity was valued at 76.182 euro, while total Liabilities amounted to 80.991 euro. Equity decreased by -15.209 euro, from 91.905 euro in 2023, to 76.182 in 2024.

Risk Reports Prices

Reviews - Decaprisept Srl

Comments - Decaprisept Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.